127 related articles for article (PubMed ID: 15618754)
21. Regulation of CYP2D expression in rat brain by toluene.
Mizuno D; Hiroi T; Ng P; Kishimoto W; Imaoka S; Funae Y
Osaka City Med J; 2003 Jun; 49(1):49-56. PubMed ID: 14703099
[TBL] [Abstract][Full Text] [Related]
22. Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters.
Anna Haduch A; Bromek E; Daniel WA
Pharmacol Rep; 2013; 65(6):1519-28. PubMed ID: 24553000
[TBL] [Abstract][Full Text] [Related]
23. Human CYP2D6 Is Functional in Brain In Vivo: Evidence from Humanized CYP2D6 Transgenic Mice.
Tolledo C; Stocco MR; Miksys S; Gonzalez FJ; Tyndale RF
Mol Neurobiol; 2020 Jun; 57(6):2509-2520. PubMed ID: 32189192
[TBL] [Abstract][Full Text] [Related]
24. Oxidation of endobiotics mediated by xenobiotic-metabolizing forms of human cytochrome.
Niwa T; Murayama N; Yamazaki H
Curr Drug Metab; 2009 Sep; 10(7):700-12. PubMed ID: 19594405
[TBL] [Abstract][Full Text] [Related]
25. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Haduch A; Rysz M; Papp M; Daniel WA
Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
[TBL] [Abstract][Full Text] [Related]
26. Characterization of cytochrome P-450 2D1 activity in rat brain: high-affinity kinetics for dextromethorphan.
Tyndale RF; Li Y; Li NY; Messina E; Miksys S; Sellers EM
Drug Metab Dispos; 1999 Aug; 27(8):924-30. PubMed ID: 10421620
[TBL] [Abstract][Full Text] [Related]
27. Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
Masubuchi Y; Iwasa T; Hosokawa S; Suzuki T; Horie T; Imaoka S; Funae Y; Narimatsu S
J Pharmacol Exp Ther; 1997 Sep; 282(3):1435-41. PubMed ID: 9316857
[TBL] [Abstract][Full Text] [Related]
28. Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain.
Haduch A; Wójcikowski J; Daniel WA
Pol J Pharmacol; 2004; 56(6):857-62. PubMed ID: 15662101
[TBL] [Abstract][Full Text] [Related]
29. Contribution of human hepatic cytochrome P450 isoforms to regioselective hydroxylation of steroid hormones.
Niwa T; Yabusaki Y; Honma K; Matsuo N; Tatsuta K; Ishibashi F; Katagiri M
Xenobiotica; 1998 Jun; 28(6):539-47. PubMed ID: 9667077
[TBL] [Abstract][Full Text] [Related]
30. Polymorphic debrisoquine 4-hydroxylase activity in the rat is due to differences in CYP2D2 expression.
Schulz-Utermoehl T; Bennett AJ; Ellis SW; Tucker GT; Boobis AR; Edwards RJ
Pharmacogenetics; 1999 Jun; 9(3):357-66. PubMed ID: 10471068
[TBL] [Abstract][Full Text] [Related]
31. Molecular basis of the Dark Agouti rat drug oxidation polymorphism: importance of CYP2D1 and CYP2D2.
Yamamoto Y; Tasaki T; Nakamura A; Iwata H; Kazusaka A; Gonzalez FJ; Fujita S
Pharmacogenetics; 1998 Feb; 8(1):73-82. PubMed ID: 9511184
[TBL] [Abstract][Full Text] [Related]
32. The Involvement of PPARs in the Selective Regulation of Brain CYP2D by Growth Hormone.
Zhang F; Li J; Na S; Wu J; Yang Z; Xie X; Wan Y; Li K; Yue J
Neuroscience; 2018 May; 379():115-125. PubMed ID: 29555426
[TBL] [Abstract][Full Text] [Related]
33. In situ hybridization study of CYP2D mRNA in the common marmoset brain.
Shimamoto Y; Niimi K; Kitamura H; Tsubakishita S; Takahashi E
Exp Anim; 2016 Nov; 65(4):465-471. PubMed ID: 27356856
[TBL] [Abstract][Full Text] [Related]
34. Guanfu base A, an antiarrhythmic alkaloid of Aconitum coreanum, Is a CYP2D6 inhibitor of human, monkey, and dog isoforms.
Sun J; Peng Y; Wu H; Zhang X; Zhong Y; Xiao Y; Zhang F; Qi H; Shang L; Zhu J; Sun Y; Liu K; Liu J; A J; Ho RJ; Wang G
Drug Metab Dispos; 2015 May; 43(5):713-24. PubMed ID: 25681130
[TBL] [Abstract][Full Text] [Related]
35. Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes.
Isobe T; Hichiya H; Hanioka N; Yamamoto S; Shinoda S; Funae Y; Satoh T; Yamano S; Narimatsu S
Biol Pharm Bull; 2005 Apr; 28(4):634-40. PubMed ID: 15802801
[TBL] [Abstract][Full Text] [Related]
36. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats.
Sakai N; Saito K; Kim HS; Kazusaka A; Ishizuka M; Funae Y; Fujita S
Drug Metab Dispos; 2005 Nov; 33(11):1657-60. PubMed ID: 16081673
[TBL] [Abstract][Full Text] [Related]
37. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody.
Nakamura A; Yamamoto Y; Tasaki T; Sugimoto C; Masuda M; Kazusaka A; Fujita S
Drug Metab Dispos; 1995 Nov; 23(11):1268-73. PubMed ID: 8591729
[TBL] [Abstract][Full Text] [Related]
38. Regulation of expression of cytochrome P-450 2D mRNA in rat brain with steroid hormones.
Baum LO; Strobel HW
Brain Res; 1997 Aug; 765(1):67-73. PubMed ID: 9310395
[TBL] [Abstract][Full Text] [Related]
39. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver.
Prueksaritanont T; Dwyer LM; Cribb AE
Biochem Pharmacol; 1995 Oct; 50(9):1521-5. PubMed ID: 7503805
[TBL] [Abstract][Full Text] [Related]
40. Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity.
Smith G; Modi S; Pillai I; Lian LY; Sutcliffe MJ; Pritchard MP; Friedberg T; Roberts GC; Wolf CR
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):783-92. PubMed ID: 9560305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
